Cytokine transcriptional events during helper T cell subset differentiation by unknown
Cytokine Transcriptional Events during Helper T  Cell 
Subset Differentiation 
By James A. Lederer,* Victor L. Perez,* Lori DeslLoches,~ 
So Mee Kim,* Abul K. Abbas,* and Andrew H. Lichtman* 
From the *Department of Surgery and the *Immunology Research Division, Department of Pathology, 
Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115 
Summary 
The molecular basis for changes in cytokine expression during T  helper (Th) cell subset differ- 
entiation is not well understood. We have characterized transcriptional events related to cyto- 
kine  gene  expression in  populations  of naive  T  cell receptor-transgenic  T  cells as  they are 
driven in vitro toward Thl  or Th2 phenotypes by interleukin  (IL)-12 or IL-4 treatment, re- 
spectively.  Quantitative  reverse  transcriptase-polymerase chain  reaction  analysis  of cytokine 
transcripts indicates that interferon (IFN) ~/, IL-4, and IL-2 mRNA are expressed with distinct 
kinetics after naive T  cells are stimulated with antigen and either IL-4 or IL-12. IFN-~/mR.NA 
appears as early as 6 h  m  IL-12-treated cultures,  IL-4 appears only after 48 h  in lL-4--treated 
cultures, and IL-2 is equivalently expressed in both types of cultures. Analyses were performed 
to determine if there were any differences in activation oflL-2 or IL-4 transcription factors that 
accompanied Thl versus Th2 differentiation. These studies demonstrated that signal transducer 
and activator of transcription 6 (STAT6) binds to a sequence in the IL-4 promoter and that this 
STAT6-binding site can support IL-4--dependent transcription  of a linked heterologous pro- 
moter. Prolonged activation of STAT6 is characteristic of populations undergoing Th2 differ- 
entiation.  Furthermore,  STAT6 is activated in an autocrine manner when differentiated Th2 
populations are stimulated by antigen receptor ligation.  Thl  populations derived from IL-12 
plus antigen treatment of naive T  cells remain responsxve to IL-4 as indicated by induction of 
STAT6 and IL-4 mRNA. These data indicate that Thl  and Th2 differentiation represents the 
combination of different,  apparently independently  regulated transcriptional events.  Further- 
more, among transcription factors that bind to the IL-4 or IL-2 promoters, STAT6 is the one 
whose activation distinguishes Th2 versus Thl development. 
T 
he development of effector populations of CD4 + Th 
cells  that produce distinct  cytokines is of central im- 
portance in infectious, allergic and autoimmune diseases (1, 2). 
Thl  cells,  which  secrete IL-2 and IFN-% are responsible 
for  phagocyte-dependent  protective  immunity  and  tissue 
injury  in  many organ-specific  autoimmune  diseases.  Th2 
cells, which produce IL-4, IL-5, and IL-10, are involved in 
the development of allergies and in defense against helmin- 
thic parasites. In addition, the cytokines produced by Th2 
cells,  especially IL-4 and IL-10, may be critical for down- 
regulating  or  suppressing  inflammation  associated  with 
Thl-mediated  immune  responses.  Experimental  evidence 
indicates  that  these  polarized  subsets  of differentiated  Th 
cells  arise  from  a  common  precursor,  which  is  a  naive 
CD4 + T  cell that produces small amounts of IL-2 and no 
detectable IFN-~/or IL-4 when stimulated for the first time 
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in vitro (3, 4). The presence of exogenous cytokines at the 
time  of primary  antigenic  stimulation  profoundly  influ- 
ences which differentiation pathway a naive T  cell will fol- 
low. Thus, IL-4 is required to drive differentiation of naive 
cells into Th2 effectors. IL-12 and IFN-~/are the principal 
cytokines  that  induce  Thl  differentiation.  There  as  some 
evidence that these cytokines, particularly IL-4 and IL-12, 
act directly on the T  cells and not on APCs. It is clear that 
IL-4 has a dominant effect over IL-12, causing Th2 differ- 
entiation even when both cytokines are present (2, 5). 
Very little is known about the molecular events that un- 
derlie T  cell subset differentiation. Studies with T  cell lines 
indicate that production of cytokines such as IL-2 and IL-4 
is controlled primarily by transient activation of transcrip- 
tion induced by the binding of nuclear factors to 5'-regula- 
tory regions of the cytokine genes (6-9). The regulation of 
IFN-~/expression may be more complex, involving meth- 
ylation of DNA and posttranscriptional events (10,  11). We 
have previously shown that in Thl and Th2 clones, the ac- 
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constructs  correlates  with  IL-2  and  IL-4  production  (6). 
Furthermore, we found that TCR-inducible nuclear trans- 
location of the p50/p65  heterodimer of nuclear factor-KB 
(NF-KB) 1 occurs in IL-2-producing Thl  and Th0  clones, 
but not in Th2  clones. It is, therefore, important to estab- 
lish if bulk populations of differentiated Thl  and Th2  cells 
show  distinct patterns of cytokine gene  transcription, and 
whether  this  correlates  with  the  activation  and  nuclear 
translocation of specific transcription factors. 
In this paper we describe our initial studies to determine 
changes  in  cytokine  gene  transcription  and  transcription 
factors during the differentiation of naive CD4 + T  cells to 
Thl and Th2 populations. The nmdel system we have used 
is the in vitro antigen plus cytokine stimulation of naive 
T  cells from  a  TCR-transgenic  mouse  line.  Such  T  cells 
have been shown  to develop into populations of Thl  and 
Th2  cells by stimulation with  antigen  and  IL-12  or  IL-4, 
respectively (12-14).  Our  experiments show  that patterns 
of cytokine gene expression are clearly different within 48 h 
of stimulation, and changes in IL-2, IL-4, and IFN-y gene 
expression occur at  distinct time points.  Furthermore,  we 
have  identified a  functionally active  site in  the  IL-4 pro- 
moter that specifically binds the IL-4-induced transcription 
factor  signal  transducer  and  activator  of  transcription  6 
(STAT6). STAT6 activation consistently and uniquely cor- 
relates with IL-4-induced Th2 differentiation. 
Materials  and Methods 
Animals.  TCR-transgenic mice expressing the AND TCR spe- 
cific for pigeon cytochrome c  (PCC) peptide 81-104 in associa- 
tion with I-E  k (15) were bred in our virus-free animal facility. All 
animals were maintained in accordance with the guidelines of the 
Committee on Animals of the Harvard Medical School and those 
prepared by the Committee on Care and Use of Laboratory Ani- 
mals of the Institute of Laboratory Resources, National Research 
Council  (DHEW  Publication  No.  [NIH]  FS-23).  Transgenic 
TCR expression was screened by PCR as previously described (5). 
Auuicen,  Cytokiues,  and Antibodies.  The antigen used in all stud- 
ies was the COOH-terminal 81-104 peptide of PCC and was ob- 
tained from the peptide synthesis facility of the Center for Neu- 
rologic Diseases,  Brigham  and Women's  Hospital.  Supernatant 
containing  recombinant  murine  IL-4  was  generated  from  the 
I3L6  cell line transfected with a constitutively expressed routine 
IL-4 eDNA (a gift of Dr. Robert Tepper, Massachusetts General 
Hospital, Boston, MA). Recombinant murine IL-12 was a gift of 
Dr. Stan Wolf (Genetics Institute, Cambridge, MA). Supernatant 
containing recombinant murine IL-2 was obtained from the IL-2 
gene-transfected X63  cell lme  (16).  The  hybridoma producing 
anti-IL-4 mAb,  11Bll,  obtained from  Dr.  William Paul  (Na- 
tional Institutes of Health, Bethesda, MD)  was  used to produce 
ascites in nude mice. 
~  Abbreviations used itt this paper: CAT, chloramphenicol acetyl tranferase; 
CF,  competitive fragment; EMSA, electrophoretic mobility shift assay; 
NFAT,  nuclear factor of activated T  cells; NF-KB, nuclear factor KB; 
PCC,  pigeon  cytochrome c;  RT,  reverse transcriptase; STAT6,  signal 
transducer and activator of transcription 6. 
Culture Conditions.  CD4;  T  cells were purified from pooled 
lymph nodes and spleens of TCR-transgenic mice by comple- 
ment-mediated lysis of MHC class II-, CD8- and JllD-express- 
ins cells, followed by depletion of remaining B  cells by panning 
on anti-Is--coated dishes, as previously described (5). These T cell 
populations were  >95%  CD3+CD4 +. T  cell differentiation was 
induced by culturing 2  X  105  purified TCR-transgenic T  cells 
with 2 X 106 APCs, 1 I.zM PCC peptide 81-104, and either lL-12 
(10 ng/ml) or IL-4 (1,000  U/ml) in 1 ml of medium. APCs were 
splenic B  cells purified from littermate B10.BR  mice by anti-Is 
panning and were treated with 50 ~g/ml mitomycin C  at 37~ 
for  30  rain,  as  described (5).  All cultures were  carried  out  in 
RPMI  1640  supplemented  with  1  mM  L-glutatnine,  sodiunt 
pyruvate,  nonessential amino  acids,  5  ￿  1(1  5 2-met and  10% 
heat-inactivated FCS (all from GIBCO BRL, Gaithersburg, MD). 
ELISA Determination of Secreted IL-2, IL-4, and IFN-%  Culture 
supematants  were assayed for the presence of IL-2, IL-4, and IFN-',/ 
using ELISA reagents from PharMingen (San Diego, CA). 
Quantitation  of  Cytokine  Transcripts  by  Reverse  Tra,scriptase- 
PCR.  After various times in culture, cells were lysed with Ultra- 
spec  RNA  extraction solution  (Biotecx,  Houston,  TX),  RNA 
was  precipitated  with  isopropanol,  washed,  and  reverse  tran- 
scribed using oligo d(T)12-18 by standard methods (17). Quanti- 
tative PCR was performed by using a competitive fragment (CF) 
that contains various cytokine eDNA sequences that yield differ- 
ent size PCR-amplification products than do endogenous cyto- 
kine cDNAs (18). The [3-actin eDNA concentration of each sam- 
ple was first determined using [3-actin--specific primers by keeping 
the cDNA concentration constant and adding serial  dilutions of 
CF.  Amplified products  were  separated on  an  agarose  gel and 
stained with ethidiurn bromide to determine the serial dilution of 
CF that gave amplified products from the CF and eDNA of equal 
intensity. The cDNA  samples were normalized to equal [3-actin 
eDNA concentrations, amplified with IL-2-, IFN-'y- and IL-4- 
specific primers, and products were separated on agarose gels. The 
eDNA concentrations were then determined from the dilution of 
CF that yielded an equal amount of amplified product as had the 
eDNA. The eDNA concentrations were calculated as attonmles 
of cDNA transcripts divided by femtomoles of input [3-actin cDNA. 
Electrophoretic Gel Mobility  Shift Assays.  Electrophoretic gel mo- 
bility shift assays (EMSA) for transcription factors were pertbrmed 
as previously described (6).  Briefly, oligonucleotides that corre- 
spond to the consensus DNA-binding elements in the nmrine 
IL-2 promoter (NFIL-2A, AP-1, NF-KB, nuclear factor of acti- 
vated T  cells [NFAT]) and IL-4 promoter (STAT6, IL-4 NFAT) 
were synthesized for use  as probes in EMSA using a DNA syn- 
thesizer (model 381A; Applied Biosystems, Inc., Foster City, CA) 
or they were purchased from Integrated DNA Technologies, Inc. 
(Coralville, IA). These oligonucleotides included: 
NFIL-2A  5 '-TATGTGTAATATGTAAAA-3  ' 
AP-1  5'-AATTCCAGAGAGTCATCAGA-3' 
NF-KB  5'-ACCAAGAGGGATTTCACCTAAATC-3' 
NFAT  5'-AAGAGGAAAATTTGTTTCATACAG-3' 
STAT6  5'-TGATTTCACAGGAAAATT-3' 
IL-4 NFAT 5'-ATAAAATTTTCCAATGTAAA-3' 
The complementary single-stranded oligonucleotides were also syn- 
thesized and annealed to  the above listed oligonucleotides, and 
the double-stranded oligonucleotides were end-labeled with .g_32p_ 
ATP (DuPont NEN Research Products, Wilmington, DE) using 
T4  polynucleotide kinase (Pharmacia LKB Biotechnology, Inc., 
Piscataway, NJ)  for use as probes in EMSA. Labeled oligonucle- 
otide was separated from unincorporated "y-32p-ATP using spin- 
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were prepared as described (6). Nuclear extract (5 ~g protein) was 
incubated for 20 min at room temperature in binding buffer (10 
mM Tris-HC1, pH 7.9, 0.1 mM EDTA, 2 mM dithiothreitol, 5% 
glycerol, and  100  mM  KC1) with --,10,000 cpm of 32p-labeled 
oligonucleotides. The  binding reactions were  then  mixed with 
6X gel-loading buffer (0.25%  bromophenol blue, 0.25% xylene 
cyanol FF, and 30% glycerol), and protein-DNA complexes were 
separated  from  free  oligonucleotide  probes  by  electrophoresis 
through  a 9%  nondenaturing polyacrylamide gel. After electro- 
phoresis, the gels were dried under vacuum and prepared for au- 
toradiography. Control experiments using 100-fold molar excess 
unlabeled oligonucleotide probes  demonstrated that  the  shifted 
protein-DNA complexes were specific for each respective oligo- 
nucleotide probe used in this study. For supershifts,  normal rabbit 
serum or antisera specific for murine STAT4 or STAT6 were added 
to the binding reactions. 
Functional Analysis of the IL-4 Promoter STA T6 Site by Transient 
Transfection.  Upper and lower strand oligonucleotides containing 
the IL-4 promoter STAT6 site sequence with 5'-phosphorylated 
TCGA overhangs were purchased from Integrated DNA Tech- 
nologies, Inc.,  annealed, ligated to  SalI-cut pBLCAT2  reporter 
construct  (19),  and  used  to  transform  Escherichia coil  Plasmid 
miniprep DNA from transformants were screened by hybridiza- 
tion to a 32p-labeled STAT6 oligonucleotide probe, and positive 
clones were sequenced. The 10g and 14g clones identified in this 
manner contain one and two tandem copies of the STAT6-bind- 
ing site, respectively. These constructs or the pBLCAT2  parent 
plasmid were  transfected  into  the  TA3  B-lymphoblastoid line 
(20) by electroporation using a Gene Pulsar instrument (Bio-Rad 
Laboratories, Richmond, CA). Transfection was performed with 
40  I.tg of DNA and 20  X  10  v cells as described previously (6). 
Electroporated cells were cultured in 5 ml culture medium for 48 h. 
IL-4 (500 U/ml) was added to some cells for the final 24 h. Cyto- 
plasmic lysates were prepared and chloramphenicol acetyl trans- 
ferase (CAT) assays were performed as described (6). 
Table 1.  Cytokine Expression After Restimulation 
Results 
Kinetics  of IL-2,  IFN-%  and IL-4  Gene Expression  during 
Th 1 and Th2 Cell Differentiation.  In  the  initial  set  of ex- 
periments,  we wished to  determine when  during in vitro 
differentiation T  cells acquired cytokine transcription pro- 
files characteristic of Thl  and Th2 subsets. To first establish 
that  cytokine secretion correlated with  mRNA  levels, we 
examined  TCR-transgenic  CD4 §  T  cells  that  had  been 
cultured with antigen, splenic B  cell APCs, and either IL-12 
or  IL-4  for  6  d,  in  order  to  induce  differentiation.  As 
shown  in  Table  1,  restimulation of cells from  6-d  IL-12- 
treated primary cultures resulted in  IL-2 and  IFN-y pro- 
duction,  but  no  detectable  IL-4  production.  In  contrast, 
cells  from  IL-4-treated  primary  cultures  produced  IL-4, 
but no detectable IFN-y and very little IL-2 upon restimu- 
lation with antigen. Thus,  as expected, IL-12 and IL-4 in- 
duce distinct patterns of Thl/Th2  differentiation. Because 
some experiments addressing the induction of IL-2 and IL-4 
transcription factors required the use ofanti-CD3 as a stim- 
ulus, we also needed to examine the phenotype of IL-12- 
and  IL-4-treated  T  cell  populations  when  restimulated 
with anti-CD3. Table 1 shows that anti-CD3-induced IL-4 
production  was  observed only in  IL-4-treated cells.  Sur- 
prisingly, anti-CD3 restimulation induced significant levels 
of IFN-',/protein in T  cells from IL-4-treated primary cul- 
tures. This was seen in three separate experiments. Further- 
more, there was some IL-2 detectable in anti-CD3-restim- 
ulated T  cells from both  IL-12- and IL-4--treated primary 
cultures. 
Cytokine transcript levels as determined by quantitative 
reverse  transcriptase  (RT)-PCR  using  competitive PCR- 
MIMICs  were  also  distinctly different  in  these  Thl  and 
Th2  populations.  Upon  restimulation,  Thl  cells  induced 
Cytokine 
Cytokine mRNA expression (atto- 
moles/femtomole [3-actin mRNA) 
Cytokine added  Restimulation 
in 1~ culture  conditions  IL-2  IFN-y  1L-4  IL-2  IFN-y  IL-4 
IL-12 
IL-4 
U/ml 
APCs  0  0  0  0.33  100  n.d. 
APCs +  PCC peptide  133  878  0  3.3  10,000  n.d. 
None  0  0  0  n.d.  < 1  n.d. 
Anti-CD3  34  664  0  3.5  100  n.d. 
APCs  0  0  0  n.d.  n.d.  n.d. 
APCs +  PCC peptide  2  0  60  0.33  1  33 
None  0  0  0  n.d.  < 1  n.d. 
Anti-CD3  5  466  51  3.5  10  100 
Cytokine secretion and mRNA expression in Thl and Th2 populations of TCR-transgenic T cells. Naive T cells from AND mice were cultured 
with splenic B cell APCs, PCC (81-104) peptide (1 ~M), and either IL-4 (1,000 U/ml) or IL-12 (10 ng/ml) as indicated, for 6 d. T cells  were then 
harvested, washed, and recultured in microwells with splenic B cell APCs minus or plus PCC peptide, no stinmlus, or plate-bound anti-CD3. RNA 
was extracted after 18 h for RT-PCR analysis  of cytokine transcripts. Quantities of cytokine mRNA were calculataed from competitive PCR shown 
in Fig. 1. Identical cultures were left for 48 h, after which supernatants were collected and analyzed for cytokine protein by ELISA. 
n.d., none detected. 
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of IL-4 gene transcripts and high levels of IL-2 and IFN-% 
whereas the IL-4--treated T  cell population had high levels 
oflL-4 gene expression and lower levels oflL-2 and IFN-21 
transcripts (Fig.  1 and summarized in Table  1).  Somewhat 
surprisingly, cells primed in  the  presence  of IL-4 and  re- 
stimulated with antigen plus APCs did express low IFN-'y 
mRNA  although  no  IFN-2r  was  detectable  by  ELISA. 
Thus, bulk populations of Thl  and Th2 TCR-transgenic T 
cells produced significantly different levels of IL-2, IFN-~, 
and IL-4 gene  transcripts. Moreover,  at the  level of cyto- 
kine  gene  transcription,  IFN-~/  and  IL-4  appear  to  most 
clearly distinguish Thl  and Th2 populations. 
We next wanted to define when during their differentia- 
tion T  cells became committed to distinct cytokine patterns. 
This  issue  can  only  be  addressed  by  measuring  cytokine 
mRNA  expression, because exogenous cytokines are present 
during in vitro differentiation. Therefore, we used quanti- 
tative R.T-PCR. analysis of IL-2, IFN-% and IL-4 m_RNA 
to determine the kinetics of differential cytokine gene ex- 
Figure 1.  Cytokine-driven Thl and Th2 differentiation of naive TCR 
transgenic T cells: determination by quantitative RT-PCP.. Naive AND 
CD4 + T cells were stimulated in vitro with PCC (81-104) peptide, B cell 
APCs, and either IL-4 or IL-12, as described in Materials and Methods. 
After 6 d, cells  were harvested, washed, and restimulated in microwells 
with splenic B cell APCs and 1 I.LM  PCC peptide, or plate-bound anti- 
CD3, as indicated, l~.estimulation  cultures were terminated at 18 h by U1- 
traspec RNA extraction solution, and amounts of IL-2 (A),  [FN-~/(B), and 
IL-4 (C) mR.NAs  were determined by quantitative  RT-PCR using iB-actin 
cDNA concentrations as internal standards. Competitive MIMICs  (CF) 
were diluted in half-log increments. (Arrows) Points of equivalent intensity 
of ethidium bromide-stained bands between cDNA and CF dilution. 
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suits  show that IL-12 enhanced IFN-~/mt(NA expression 
as early as 6 h after initial stimulation, and that IFN-~/gene 
expression  remained  significantly  higher  in  the  IL-12- 
treated cultures than in the untreated or IL-4-treated cul- 
tures throughout the differentiation process. A striking ob- 
servation was that  IL-4 gene  expression was not  detected 
until  48  h  after stimulation  of naive  T  cells  with  antigen 
and IL-4. The expression of IL-2 was not significantly af- 
fected b~, IL-12 and IL-4 treatment, even at 48 h when IL-4 
gene expression was the highest in the IL-4-treated stimu- 
lation cultures. 
These results indicate that changes in expression of IL-2, 
IL-4,  and  IFN-~/  genes  during  subset  differentiation  are 
temporally distinct events, suggesting that they may be reg- 
ulated in different ways. In vitro differentiation of naive T 
cells is associated with clearly polarized patterns of IL-4 and 
IFN-',/ gene transcription within  48  h.  Early transcription 
of IL-2 is not distinct in  these  differentiating T  cells,  and 
the diminished expression of the IL-2 gene in Th2 popula- 
tions is only observed after restimulating cells that have dif- 
ferentiated in the presence of IL-4. 
Analysis of lL-2 and IL-4 Promoter-specific Transcription Fac- 
tors in Th 1 and Th2 Cell Populations.  The expression of cy- 
tokine genes is controlled,  in part, by sets of transcription 
factors  that  bind  to  cytokine  promoters.  We  conducted 
EMSA analyses in order to determine if the distinct patterns 
of cytokine gene transcription in T  cell populations under- 
going Thl versus Th2 differentiation could be attributed to 
distinct patterns of transcription factor activation. The well 
characterized  regulatory  elements  within  the  IL-2  gene 
promoter include AP-1, NFIL-2A (Oct-1/OAP-40), NFAT, 
and  NF-KB  (9).  The  IL-4  promoter  contains  multiple 
NFAT sites that have been shown to be involved in regula- 
tion  of IL-4  gene  expression  (7,  21).  Recently,  several 
groups have described a transcription  factor that becomes 
tyrosine  phosphorylated and  rapidly translocates  from the 
cytoplasm to the nucleus in response to IL-4-induced sig- 
nals. This factor, called STAT6 or IL-4STAT, binds to sites 
in  the  5'  regulatory  regions  of several  IL-4-responsive 
genes that have an inverted repeat spaced by three nucle- 
otides that is characteristic of several described cytokine re- 
sponse- or STAT factor-binding sites  (22-24).  Compari- 
son  of these  sequences  with  the  murine  IL-4  promoter 
sequences revealed a potential binding site located at -153 
to  -167  from the  transcriptional  initiation  site  within  the 
routine IL-4 promoter. This site partially overlaps a previ- 
ously  identified  NFAT-binding  site  (7).  Thus,  for  the 
EMSA  assays  in  these  studies,  we  used  oligonucleotide 
probes  corresponding  to  the  AP-I-,  NFIL-2A  (Oct-l/ 
OAP-40)-, NFAT-, and NF-KB-binding sequences of the 
routine IL-2 gene promoter, and the NFAT- and STAT6- 
binding sites from the murine IL-4 promoter. 
When we compared cells from IL-4- and IL-12-treated 
cultures,  we observed no significant difference in the nu- 
clear presence of IL-2 promoter-binding factors, including 
AP-1, NFAT, NFIL-2A, and NF-KB. This was true early 
during T  cell differentiation, i.e.,  48 h  after stimulation of 
naive T  cells with IL-12 or IL-4 (Fig.  3), and even in cells 
that had been differentiated for 6  d  and were restimulated 
(Fig.  4). Parallel assays for cytokine secretion by 6-d differ- 
entiated populations showed that Thl  and Th2 differentia- 
tion  had  occurred  in  these  IL-12- and  IL-4-treated cul- 
tures,  respectively  (data  not  shown).  Although  we  have 
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Figure 2.  Kinetics  of cytokine mRNA expression in differentiating CD4 § T cells: quantitative I:(T-PCt( analysis. Differentiation cultures were set up 
as described in Fig. 1. RNA was isolated from the cultures at the indicated time points and reverse transcribed IL-2, IFN-~, and IL-4  mI(NA was ana- 
lyzed hy quantitative I~T-PCIk. 
401  Lederer et al. Figure 3.  Nuclear  transcription  factors in differentiating  Thl and Th2 
populations. TCR transgenic  T cells were cultured with splenic B cell 
APCs, antigen, and either IL-12 or IL-4, as described in Materials and 
Methods. After 48 h of culture, nuclear extracts were prepared and ana- 
lyzed by EMSA for the presence of DNA-binding proteins using  oligonu- 
cleotide probes containing  binding sites for the indicated  factors. 
previously observed a lack of NF-KB activation in TCR- 
stimulated Th2 clones that do not transcribe the IL-2 gene, 
the finding here that NF-KB activation does occur in stim- 
ulated Th2-1ike populations is consistent with the fact that 
these cells do express IL-2 transcripts (Fig. 1 A). The lack of 
TC1K-inducible NF-KB activation may be a phenotype of 
cells that have undergone multiple rounds of differentiation. 
Among the  IL-4 promoter-binding proteins, we  found 
no difference in nuclear proteins that bind to an IL-4 NFAT 
site,  but there was  a  distinct difference in EMSA patterns 
using an oligonucleotide probe corresponding to the puta- 
tive STAT6-binding  sequence in the mouse IL-4-promoter. 
STAT6 protein was detected in the nuclei of IL-4-treated 
T  cells at  48  h  after initiation of cultures, the  time point 
during differentiation when  we  first  detect  IL-4  mlKNA 
(Fig. 2). Supershift analysis using a murine STAT6-specific 
antibody indicated that STAT6 was in fact present in the 
IL-4-induced gel-shift complex detected with this probe. 
The  anti-STAT6 serum,  but  not  anti-STAT4 or  preim- 
mune sera,  supershifted  complexes  of the  probe  and nu- 
clear proteins  from  IL-4-treated TCR-transgeuic T  cells 
(Fig. 5), as well as complexes formed with nuclear extracts 
from  anti-CD3-treated TCR-transgenic Th2  populations 
(not shown). Kinetic analysis showed that nuclear STAT6 
was  also detectable as  early as  24  h  after culture initiation 
(Fig.  6),  indicating that  STAT6  activation precedes  IL-4 
gene  transcription.  Thus,  antigen  stimulation of a  naive 
population of T  cells in the presence of IL-4 leads to  the 
induction of STAT6 proteins before and during the time of 
Figure 4.  Nuclear  transcription  factors in restimulated Thl  and Th2 
cells. Identical  cultures  to those described in Fig, 3 were continued for 6 d, 
at which time cells were harvested and restimulated  with anti-CD3. Nu- 
clear extracts were prepared from these restimulation cultures 3 h after 
initiation, and were analyzed  by EMSA. 
differentiation when IL-4 gene transcript levels peak.  IL-4 
induction of STAT6 is generally a transient event with nu- 
clear STAT6 waning after 2  h  (24,  and data not shown). 
Interestingly, the presence of nuclear STAT6 at either 24 
or 48 h  appeared to be dependent on both the presence of 
IL-4 and antigen stimulation, suggesting that other signals 
besides those induced by IL-4 were required for sustained 
activation of STAT6 (Fig.  3  and 6).  No  STAT6 was  de- 
tectable in cells from IL-12-treated primary cultures. Nu- 
clear STAT6 was also induced by anti-CD3 restimulatiou 
of cells from IL-4-treated primary cultures, but not from 
IL-12-treated primary cultures (Fig. 4). 
Figure 5.  Identification  of STAT6 in gel-shift complexes using a probe 
with a routine IL-4 promoter sequence. TCR-transgenic T cells were 
cultured with splenic  B cell APCs, antigen, and IL-4 for 6 d, as described 
in Figs. 3 and 4, and then restmmlated with 500 U/lnl IL-4 for 30 min 
followed by nuclear extract preparation. EMSA analyses  were perfonned 
using these extracts and the STAT6 probe corresponding  to a sequence in 
the nmrine IL-4 promoter (see Materials and Methods). Antisera specific 
for normal rabbit serum, murine STAT4 (negative controls), or murine 
STAT6 were added to the binding reactions, as indicated. (arrowhead) Lo- 
cation of the STAT6-containing  complexes. 
402  Cytokine Gene Transcription during Thl and Th2 Differentiation Figure 6.  Nuclear  STAT6 in 24-h Th2-differentiating  cultures. Naive 
TCR-transgenic T cells were stimulated with APes, antigen, and cyto- 
kines as described in previous  figures. Nuclear  lysates were prepared at 24 h 
after culture initiation and were analyzed  by EMSA for the presence of 
factors binding to the IL-4 promoter STAT6 site. 
STAT6, like other cytokine-inducible  STAT proteins, is 
activated and translocated to the nucleus after exposure of 
cells to  IL-4.  Since we  observed STAT6 in differentiated 
Th2 cells stimulated with antigen or anti-CD3 (in the ab- 
sence of added IL-4), this raised the possibility that STAT6 
was  induced by the  autocrine effect  of secreted  IL-4.  To 
test this, differentiated Th2 cells were stimulated with anti- 
CD3  in  the  presence  of anti-IL-4 antibody,  and  nuclear 
STAT6 was assayed by EMSA. Anti-IL-4 antibody partially 
blocked the appearance of nuclear STAT6 in restimulated 
Th2  populations  (Fig.  7),  indicating that  autocrine  IL-4 
was responsible for at least part of the induction of STAT6 
in these cultures. The failure to  completely block STAT6 
induction with anti-IL-4 antibody may reflect the high sen- 
sitivity of this signaling pathway to small amounts of IL-4, 
or  direct  effects  of TCR  signaling on  STAT6  activation 
that are independent of IL-4. 
Reversibility  of  Till  and  Th2  Populations  and  Correlation 
with STAT6.  Recently, it has been shown that bulk pop- 
ulations of Thl cells can be converted to IL-4 producers by 
culture with IL-4, but Th2 populations appear to be irre- 
versibly committed (5,  25,  26).  The stability of Th2  cells 
Figure 7.  Exogenous IL-4 activation  of STAT6 in Thl cells  and auto- 
crine activation  of STAT6 in Th2 cells. TCR-transgenic T cells  were dif- 
ferentiated in the presence of B cell APCs, antigen, and either IL-12 or 
IL-4 for 6 d and were then recultured  with no added stimulus,  anti-CD3, 
IL-4, or anti-CD3 plus anti-IL-4 (1/1,000 dilution of 11B11 ascites) as 
indicated. Nuclear lysates were prepared after 3 h ofrestimulation and an- 
alyzed for the presence of STAT6, as described in previous figures. 
may in part be explained by the fact that these cells are un- 
able to transduce IL-12-induced signals, including the acti- 
vation of STAT3 and STAT4 (26).  If STAT6 is important 
in inducing Th2  differentiation, then both  Thl  and Th2 
populations should be able to activate STAT6. To test this 
hypothesis, Thl and Th2 populations generated by 6-d cul- 
tures of naive T  cells with IL-12 or IL-4 were restimulated 
with anti-CD3 alone or with anti-CD3 plus IL-4, and nu- 
clear STAT6 was assessed  by EMSA. We found that both 
IL-12-pretreated Thl populations and IL-4-pretreated Th2 
populations translocated STAT6 to the nucleus in response 
to  IL-4  (Fig.  7).  This  correlated  with  the  enhanced ex- 
pression of IL-4 mRNA  in Thl populations by 48 h  after 
restimulation with anti-CD3 plus IL-4 (Table 2), Thl pop- 
ulations also  expressed  abundant IFN-~/  mRNA  without 
antigen  stimulation,  and  this  was  suppressed  by  antigen 
stimulation in the presence of IL-4. In contrast to the pri- 
mary cultures, IL-2 mRNA was no longer detectable in ei- 
ther Thl or Th2 populations at 48 h  after restimulation. 
Functional  Analysis  of the  Murine  IL-4  Promoter  STA T6- 
binding  Site.  To demonstrate that the STAT6-binding  site 
identified in the IL-4 promoter can function to enhance tran- 
scription, we prepared reporter gene constructs containing 
one or two copies of this site linked to promoter- CAT se- 
quences  and  introduced these  DNAs  into  the  efficiently 
transfectable TA3 lymphoblastoid line. EMSA analyses in- 
Table 2.  Cytokine mRNA Expression in Th I and Th2 Cell 
Populations Restimulated  in the Presence of lL-4 or IL-12 
Cytokine 
added in 
1~ culture  Restimulation conditions 
Cytokine mRNA 
expression 
(attomoles/ 
femtomole 
[3-actin mRNA) 
IL-2  IFN-~/  IL-4 
IL-12 
IL-4 
APCs  <3  10  <3 
APCs +  PCC peptide  <3  30  <3 
APCs +  IL-12  <3  100  <3 
APCs +  PCC peptide +  IL-12  <3  100  <3 
APCs  +  IL-4  <3  100  <3 
APCs +  PCC peptide +  IL-4  <3  10  10 
APCs  <3  <3  3 
APCs +  PCC peptide  <3  <3  30 
APCs +  IL-12  <3  30  3 
APCs +  PCC peptide +  IL-12  <3  <3  30 
APCs +  IL-4  <3  <3  3 
APCs +  PCC peptide +  IL-4  <3  <3  100 
Thl and Th2 populations were derived in vitro as described in Table 1, 
and cells were restimulated with B cell APCs plus PCC peptide in the 
presence of no cytokine, IL-4 (1,000/ml), or IL-12 (10 ng/ml). Cul- 
tures were terminated at 48 h and cytokine mRNA expression  was de- 
termined by quantitative RT-PCR as described in Fig. 1. 
403  Lederer et al. Table 3.  Functional  analysis of the IL-4 Gene 5" 
STA T6-binding  Site 
Plasmid  Number of STAT6 sites  Fold induction by IL-4 
pBLCAT2  None  0.6 
10g  1  1.0 
14g  2  4.0 
TA3 cells were transfected with the indicated CAT-reporter  plasmids 
by electroporation. The cells were stimulated with 1,000 U/ml IL-4 at 
24 h, and CAT activity was assayed by phase extraction liquid scintilla- 
tion (see Matenals and Methods) in cell lysates prepared at 48 h. Fold 
induction was calculated as counts per minute from IL-4-treated cells 
divided by Counts per minute from untreated cells. A representative 
experiment is shown.  [L-4 induction of CAT activity in  cells trans- 
(ected with the 14g plasmid was observed in three independent experi- 
ments. 
dicated  that  IL-4 treatment  leads  to  STAT6  activation  in 
these  cells  (data not shown).  The data  in Table  3  indicate 
that  the  IL-4 promoter  STAT6  site  does  support  IL-4- 
enhanced transcription of a linked reporter gene. 
Discussion 
These  studies  were  undertaken  to  characterize  changes 
in  transcriptional  regulation  of cytokine  genes  during  Th 
cell subset  differentiation.  The kinetics  of IL-4,  IL-2, and 
IFN-y mRNA  expression that we observed in differentiat- 
ing cultures ofCD4 + T  cells  indicates temporally indepen- 
dent regulation of the expression of different cytokine genes. 
IFN-~, transcripts appear early, within 24 h, in populations 
differentiating toward a  Thl  phenotype.  In contrast,  IL-4 
transcripts do not appear until  48 h  in cells differentiating 
towards a Th2 phenotype.  IL-2 transcripts are detectable at 
6  h  and  no  difference  is  seen  in  the  appearance  of IL-2 
transcripts  in primary cultures differentiating toward either 
Thl  or Th2 phenotypes. This observation is not surprising 
since it is known that IL-2 is required for both differentia- 
tion pathways (27). Thus, there does not appear to be a sin- 
gle  switch  event  during  subset  differentiation  that  affects 
multiple cytokine genes at the same time. 
The  only clear difference  we  observed  in nuclear tran- 
scription  factors between  cultures  of differentiating  CD4 + 
cells was the presence of STAT6 in cells  driven toward the 
Th2  phenotype.  STAT6  has  been  identified  as  a  protein 
that  binds  to  DNA  sequences  found  in  the  promoters  of 
IL-4-responsive genes  (22,  24)  A  cDNA encoding a pro- 
tein that binds to the  IL-4 response element in the human 
FcyP, l  gene has been cloned and sequenced (14). The pre- 
dicted  protein  product  of this  cDNA shares  features  with 
other  STAT  family  members  and  it  contains  regions  that 
can  apparently  bind  to  the  cytoplasmic  tail  of  IL-4R. 
STAT6  activation  is  thought  to involve  association  of la- 
tent monomers with the IL-41:k,  tyrosine phosphorylation, 
dimerization,  and  translocation  to  the  nucleus,  where  the 
dinners  bind to response elements in the promoters of vari- 
ous  genes.  Recently,  it  has been  reported  that  mice with 
targeted  disruptions  of the  STAT6  gene  are  incapable  of 
mounting  Th2  responses  (28-30).  These  studies  confirm 
the essential role of IL-4 signaling in promoting Th2 differ- 
entiation, but they do not indicate how IL-4 may induce T 
cells  to become competent at transcribing  their  own IL-4 
genes.  The  identification  of a  functional  STAT6-binding 
site in the IL-4 promoter reported here, and the correlation 
of STAT6  activation  with  Th2  differentiation,  implicate 
that  STAT6  is  involved directly  with  IL-4 transcriptional 
activity during Th2 differentiation. 
Gel  shift assays  using nuclear extracts from IL-4-treated 
THP-1  cells  and a sequence from the human FcyRl  gene 
demonstrated  rapid  indcution  of STAT6 activity,  within 
5  min,  and  a  rapid  decay,  within  2  h  (24).  We have seen 
similar kinetics  in mouse T  cells,  using an oligonucleotide 
probe  with  a  murine  IL-4  promoter  sequence  (Lederer, 
J.A.,  and  A.H.  Lichtman,  unpublished  observation).  A 
longer half-life for nuclear STAT6 was reported in HepG2 
cells using an interferon  response factor  1 y  activation site 
(GAS) probe, which binds a variety of STAT family mem- 
bers  (11). We found that STAT6 was present in the nuclei 
of IL-4-treated cells  at 24 and 48  h  as well  as in restimu- 
lated  Th2  cells  derived  from  6-d  IL-4-treated  cultures. 
Thus,  STAT6  remains  consistently  activated  before  and 
during  the  onset  of IL-4 gene  transcription  in  these  cul- 
tures.  The sustained presence of nuclear STAT6 days after 
the  initial  exposure  to IL-4, as well  as the  antigen-depen- 
dence  of STAT6 activation after 24 h,  suggests that  other 
signals  besides  those  provided  by  the  exogenously  added 
IL-4  are  responsible  for  maintaining  STAT6  activation. 
Clearly, autocrine  IL-4 production can induce STAT6 ac- 
tivation,  as we observed in restimulated Th2 cells.  Thus,  it 
is possible  that autocrine  IL-4 can  contribute  to  the  tran- 
scriptional  regulation  of the  IL-4 gene  after the  effects  of 
exogenous sources of IL-4 have waned. 
A  recently reported  study with  TCR-transgenic  T  cells 
has  demonstrated  that  there  is  an  extinction  of IL-12 sig- 
naling in populations  differentiating  toward the  Th2  phe- 
notype (16).  IL-  12-signaling pathways involve tyrosine phos- 
phorylation  of STAT3  and  STAT4.  T  cells  undergoing 
Th2 differentiation may fail to generate the active forms of 
these transcription factors at the same time that they gener- 
ate active STAT6 in response  to exogenous and autocrine 
IL-4. Thus, it is possible that an abundance of STAT3 and 
STAT4  in  the  nucleus  of a  T  cell  at  the  time  of antigen 
stimulation favors commitment to a Thl phenotype, whereas 
a relative abundance  of STAT6 favors Th2 differentiation. 
Since the presence of STAT6 correlates with Th2 differen- 
tiation,  it is important  to determine  the  functional signifi- 
cance  of STAT6  binding  to  the  IL-4 promoter.  We  are 
currently using mutational analyses and reporter gene trans- 
fections  to  formally  test  the  role  of STAT6  in  transcrip- 
tional activation of the IL-4 gene. To date, there is no evi- 
dence indicating that STAT3 or STAT4 bind to regulatory 
sequences  of the  IFN-3' or IL-2 genes  and  regulate  their 
transcription. 
The  lack  of correlation  of subset  differentiation  with 
404  Cytokine Gene Transcription  during Thl and Th2 Differentiation other  transcription  factors,  including AP-1,  NF-AT,  and 
NFIL-2A, indicates that these factors may not be key de- 
terminants  of early  commitment  towards  a  Thl  or  Th2 
phenotype. This finding is consistent with the observation 
that IL-2 gene transcription is not modulated early during 
the T  cell differentiation process and that upon restimula- 
tion, both Thl  and Th2  populations have  the  capacity to 
express  IL-2.  Perhaps  multiple  rounds  of stimulation  by 
chronic antigen exposure lead to a  more pronounced seg- 
regation of IL-2 expression in Th  cells similar to what has 
been observed in T  cell clones and in Thl  and Th2 popu- 
lations after multiple rounds of restimulation (6, 31). 
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